Literature DB >> 29426692

Pancreatic gross tumor volume contouring on computed tomography (CT) compared with magnetic resonance imaging (MRI): Results of an international contouring conference.

William A Hall1, Hanne D Heerkens2, Eric S Paulson3, Gert J Meijer2, Alexis N Kotte2, Paul Knechtges4, Parag J Parikh5, Michael F Bassetti6, Percy Lee7, Katharine L Aitken8, Manisha Palta9, Sten Myrehaug10, Eugene J Koay11, Lorraine Portelance12, Edgar Ben-Josef13, Beth A Erickson3.   

Abstract

PURPOSE: Accurate identification of the gross tumor volume (GTV) in pancreatic adenocarcinoma is challenging. We sought to understand differences in GTV delineation using pancreatic computed tomography (CT) compared with magnetic resonance imaging (MRI). METHODS AND MATERIALS: Twelve attending radiation oncologists were convened for an international contouring symposium. All participants had a clinical and research interest in pancreatic adenocarcinoma. CT and MRI scans from 3 pancreatic cases were used for contouring. CT and MRI GTVs were analyzed and compared. Interobserver variability was compared using Dice's similarity coefficient (DSC), Hausdorff distances, and Jaccard indices. Mann-Whitney tests were used to check for significant differences. Consensus contours on CT and MRI scans and constructed count maps were used to visualize the agreement. Agreement regarding the optimal method to determine GTV definition using MRI was reached.
RESULTS: Six contour sets (3 from CT and 3 from MRI) were obtained and compared for each observer, totaling 72 contour sets. The mean volume of contours on CT was significantly larger at 57.48 mL compared with a mean of 45.76 mL on MRI, P = .011. The standard deviation obtained from the CT contours was significantly larger than the standard deviation from the MRI contours (P = .027). The mean DSC was 0.73 for the CT and 0.72 for the MRI (P = .889). The conformity index measurement was similar for CT and MRI (P = .58). Count maps were created to highlight differences in the contours from CT and MRI.
CONCLUSIONS: Using MRI as a primary image set to define a pancreatic adenocarcinoma GTV resulted in smaller contours compared with CT. No differences in DSC or the conformity index were seen between MRI and CT. A stepwise method is recommended as an approach to contour a pancreatic GTV using MRI.
Copyright © 2017 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 29426692     DOI: 10.1016/j.prro.2017.11.005

Source DB:  PubMed          Journal:  Pract Radiat Oncol        ISSN: 1879-8500


  4 in total

Review 1.  Basics and Frontiers on Pancreatic Cancer for Radiation Oncology: Target Delineation, SBRT, SIB technique, MRgRT, Particle Therapy, Immunotherapy and Clinical Guidelines.

Authors:  Francesco Cellini; Alessandra Arcelli; Nicola Simoni; Luciana Caravatta; Milly Buwenge; Angela Calabrese; Oronzo Brunetti; Domenico Genovesi; Renzo Mazzarotto; Francesco Deodato; Gian Carlo Mattiucci; Nicola Silvestris; Vincenzo Valentini; Alessio Giuseppe Morganti
Journal:  Cancers (Basel)       Date:  2020-06-29       Impact factor: 6.639

2.  Daily breathing inconsistency in pancreas SBRT: a 4DCT study.

Authors:  Vikren Sarkar; Shane Lloyd; Adam Paxton; Long Huang; Fan-Chi Su; Randa Tao; Jonathan Tward; Hui Zhao; Bill Salter
Journal:  J Gastrointest Oncol       Date:  2018-12

3.  Clinicopathological correlation of radiologic measurement of post-therapy tumor size and tumor volume for pancreatic ductal adenocarcinoma.

Authors:  Dongguang Wei; Mohamed M Zaid; Matthew H Katz; Laura R Prakash; Michael Kim; Ching-Wei D Tzeng; Jeffrey E Lee; Anshuman Agrawal; Asif Rashid; Hua Wang; Gauri Varadhachary; Robert A Wolff; Eric P Tamm; Priya R Bhosale; Anirban Maitra; Eugene J Koay; Huamin Wang
Journal:  Pancreatology       Date:  2020-11-14       Impact factor: 3.996

Review 4.  Magnetic Resonance Guided Radiation Therapy for Pancreatic Adenocarcinoma, Advantages, Challenges, Current Approaches, and Future Directions.

Authors:  William A Hall; Christina Small; Eric Paulson; Eugene J Koay; Christopher Crane; Martijn Intven; Lois A Daamen; Gert J Meijer; Hanne D Heerkens; Michael Bassetti; Stephen A Rosenberg; Katharine Aitken; Sten Myrehaug; Laura A Dawson; Percy Lee; Cihan Gani; Michael David Chuong; Parag J Parikh; Beth A Erickson
Journal:  Front Oncol       Date:  2021-05-11       Impact factor: 5.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.